Cancer Research UK & UCL Cancer Trials Centre (H01) The Cancer Research UK and UCL Cancer Trials Centre (CTC) is one of the largest dedicated cancer trials units in the UK. It was formed in 1997, and is now a research department within the UCL Cancer Institute. The CTC develops and conducts high quality studies to find new ways of treating or detecting cancer, and understanding mechanisms of how cancer develops. It has established collaborations with clinicians and scientists, nationally and internationally, to generate new scientific research proposals, develop laboratory projects associated with CTC studies, and train a new generation of clinical trials specialists. Studies are conducted in a wide range of tumours, primarily, lung, lymphoma, gastrointestinal, head and neck, gynaecology, brain, and sarcoma. Cancer Research UK provides the main source of core funding, with additional core support from the Lymphoma Research Trust. Individual projects are funded by competitive grants from Cancer Research UK, the Lymphoma Research Trust, the Medical Research Council, NIHR, and major pharmaceutical companies. FOR ALL QUERIES PLEASE USE THE CONTACT TABS FOUND IN EACH OF THE INDIVIDUAL COURSES/CONFERENCES AND PRODUCTS, PLEASE ONLY CONTACT THE ONLINE STORE DIRECTLY IF YOU ARE EXPERIENCING PAYMENT DIFFICULTIES. Cancer Research UK & UCL Cancer Trials Centre (H01)H01 PIS Workshop How To Design Clear & Accessible Patient Information Sheets 080725DescriptionPatient Information Sheets (PIS) are a key document for potential participants to make an informed decision about whether to take part in a clinical study. While there is clear guidance from the Health Research Authority (HRA) on content and regulatory requirements, PIS are customised for each clinical trial and the specific patient population. Choosing the right language and format for patient facing materials for research studies and clinical trials still greatly varies and depends on the skills and experience of the team putting them together.
Course tutors: Linda Von Neree, Patient and Public Involvement and Engagement (PPIE) Lead, BRTU PPI.
H01 Trial Outcomes - What Are We Trying To Measure 030725DescriptionThis session, aimed at non-statisticians, will cover the most common primary outcomes measures used in early and late phase cancer trials. Learning Outcomes: Participants will learn what makes a good outcome measure, how outcomes measures are defined and what data need to be collected to assess the outcome, especially for tumour response assessment and time to event measures such as survival and disease (or progression) free survival.
This course runs from 10:00am until 13.00pm
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
London's global university
Managed by UCL Finance University College London - Gower Street - London - WC1E 6BT Email: uclonlinestore@ucl.ac.uk
© UCL 1999–2012, UCL is a Company Incorporated by Royal Charter (England/Wales), number: RC000631 VAT number: GB 524 3711 68
